Satellos to Present at the 31st Annual Congress of the World Muscle Society
Satellos Bioscience will present four posters at the 31st Annual Congress of the World Muscle Society, held in Hiroshima, Japan, from Sept. 29 to Oct. 3, 2026. Two posters cover the BASECAMP Phase 2a dose-comparison study and the TRAILHEAD open-label long-term study of forazapadin (SAT-3247) in Duchenne muscular dystrophy, both presented by Dr.
Key figures
- Drug Name
- Forazapadin (SAT-3247)
- Phase Of Trial
- Phase 2
- Congress
- 31st Annual Congress of the World Muscle Society, Hiroshima, Japan, Sept. 29 - Oct. 3, 2026
- Cash runway
- through 2027
- Poster count
- 4
- Fshd ind submission timing
- second half of 2026
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.